Journal of Neuro-Oncology, Год журнала: 2024, Номер 167(1), С. 229 - 230
Опубликована: Фев. 16, 2024
Язык: Английский
Journal of Neuro-Oncology, Год журнала: 2024, Номер 167(1), С. 229 - 230
Опубликована: Фев. 16, 2024
Язык: Английский
Annals of Surgical Oncology, Год журнала: 2024, Номер unknown
Опубликована: Ноя. 18, 2024
Abstract Background Primary tracheal cancers (PTCs) are rare neoplasms underreported in the literature. No consensus guidelines exist for treatment of these and multimodal management has not been adequately explored cases diagnosed over past 2 decades. Methods The Surveillance, Epidemiology, End Results (SEER) database was queried to identify patients with PTC. Cox proportional hazards log-rank testing used assess association between demographic variables 5-year cause-specific survival (CSS). Among 689 identified patients, age < 65 years at diagnosis (hazard ratio [HR] 0.64, p 0.001), non-squamous cell carcinoma (SCC) histology (HR 0.22, surgery 0.43, 0.001) were all associated increased CSS. Regarding disease histology, adenoid cystic carcinomas (ACCs) had CSS compared those neither SCC nor ACC (83.4% [76.0%, 90.8%] versus 50.3% [42.5%, 58.1%] 28.8% [23.2%, 34.4%]; based on univariate analysis. Despite improved surgery, 55% cohort did undergo only 5.5% having 58% ( 0.001). Conclusions Age years, among PTC, although significant proportion this group receiving represents an opportunity outcomes.
Язык: Английский
Процитировано
1Journal of Neuro-Oncology, Год журнала: 2024, Номер 167(1), С. 229 - 230
Опубликована: Фев. 16, 2024
Язык: Английский
Процитировано
0